Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
45.71B | 44.99B | 46.59B | 46.70B | 47.27B | 50.68B | Gross Profit |
4.31B | 3.60B | 3.54B | 3.75B | 3.53B | 4.12B | EBIT |
1.13B | 509.00M | 439.00M | 665.00M | 661.00M | 1.06B | EBITDA |
3.28B | 2.94B | 2.84B | 3.02B | 2.93B | 2.96B | Net Income Common Stockholders |
1.01B | 416.00M | 316.00M | 465.00M | 475.00M | 905.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
2.10B | 1.97B | 2.23B | 1.84B | 2.94B | 3.33B | Total Assets |
37.03B | 36.89B | 37.69B | 39.11B | 41.05B | 40.86B | Total Debt |
790.00M | 1.37B | 2.51B | 4.43B | 5.71B | 6.23B | Net Debt |
-1.31B | -588.00M | 280.00M | 2.60B | 2.77B | 2.90B | Total Liabilities |
11.41B | 11.88B | 13.21B | 14.99B | 17.20B | 17.82B | Stockholders Equity |
25.35B | 24.73B | 24.16B | 23.78B | 23.56B | 22.72B |
Cash Flow | Free Cash Flow | ||||
0.00 | 985.00M | 2.43B | 217.00M | 216.00M | -1.02B | Operating Cash Flow |
0.00 | 2.59B | 3.46B | 2.18B | 2.74B | 2.18B | Investing Cash Flow |
0.00 | -1.27B | -918.00M | -1.98B | -2.40B | -3.06B | Financing Cash Flow |
0.00 | -1.46B | -2.19B | -1.51B | -773.00M | 2.12B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥5.39B | 11.57 | 2.03% | 4.81% | -6.89% | ||
75 Outperform | ¥21.54B | 9.02 | 3.33% | 3.60% | 16.83% | ||
74 Outperform | ¥17.17B | 7.44 | 2.74% | 1.73% | -2.77% | ||
73 Outperform | ¥6.76B | 7.06 | 2.10% | 1.73% | -61.62% | ||
66 Neutral | $4.48B | 12.26 | 5.32% | 248.53% | 4.10% | -12.36% | |
65 Neutral | ¥11.24B | 10.07 | 4.88% | 2.56% | 168.27% | ||
63 Neutral | ¥3.79B | 35.05 | 0.81% | 0.09% | 76.91% |